Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
1.
ScientificWorldJournal ; 2014: 893981, 2014.
Article in English | MEDLINE | ID: mdl-25386621

ABSTRACT

Clonorchis sinensis and Opisthorchis viverrini are both important fish-borne pathogens, causing serious public health problem in Asia. The present study developed an assay integrating real-time PCR and high resolution melting (HRM) analysis for the specific detection and rapid identification of C. sinensis and O. viverrini. Primers targeting COX1 gene were highly specific for these liver flukes, as evidenced by the negative amplification of closely related trematodes. Assays using genomic DNA extracted from the two flukes yielded specific amplification and their identity was confirmed by sequencing, having the accuracy of 100% in reference to conventional methods. The assay was proved to be highly sensitive with a detection limit below 1 pg of purified genomic DNA, 5 EPG, or 1 metacercaria of C. sinensis. Moreover, C. sinensis and O. viverrini were able to be differentiated by their HRM profiles. The method can reduce labor of microscopic examination and the contamination of agarose electrophoresis. Moreover, it can differentiate these two flukes which are difficult to be distinguished using other methods. The established method provides an alternative tool for rapid, simple, and duplex detection of C. sinensis and O. viverrini.


Subject(s)
Clonorchiasis/parasitology , Clonorchis sinensis/isolation & purification , Cyclooxygenase 1/isolation & purification , Opisthorchiasis/parasitology , Opisthorchis/isolation & purification , Animals , Asia , Clonorchiasis/transmission , Clonorchis sinensis/genetics , Clonorchis sinensis/pathogenicity , Cyclooxygenase 1/genetics , Fishes/parasitology , Humans , Opisthorchiasis/transmission , Opisthorchis/genetics , Opisthorchis/pathogenicity , Real-Time Polymerase Chain Reaction/methods
2.
J Lipid Res ; 53(7): 1336-47, 2012 Jul.
Article in English | MEDLINE | ID: mdl-22547204

ABSTRACT

Recombinant human prostaglandin endoperoxide H synthase-1 (huPGHS-1) was characterized. huPGHS-1 has a single high-affinity heme binding site per dimer and exhibits maximal cyclooxygenase (COX) activity with one heme per dimer. Thus, huPGHS-1 functions as a conformational heterodimer having a catalytic monomer (E(cat)) with a bound heme and an allosteric monomer (E(allo)) lacking heme. The enzyme is modestly inhibited by common FAs including palmitic, stearic, and oleic acids that are not COX substrates. Studies of arachidonic acid (AA) substrate turnover at high enzyme-to-substrate ratios indicate that nonsubstrate FAs bind the COX site of E(allo) to modulate the properties of E(cat). Nonsubstrate FAs slightly inhibit huPGHS-1 but stimulate huPGHS-2, thereby augmenting AA oxygenation by PGHS-2 relative to PGHS-1. Nonsubstrate FAs potentiate the inhibition of huPGHS-1 activity by time-dependent COX inhibitors, including aspirin, all of which bind E(cat). Surprisingly, preincubating huPGHS-1 with nonsubstrate FAs in combination with ibuprofen, which by itself is a time-independent inhibitor, causes a short-lived, time-dependent inhibition of huPGHS-1. Thus, in general, having a FA bound to E(allo) stabilizes time-dependently inhibited conformations of E(cat). We speculate that having an FA bound to E(allo) also stabilizes E(cat) conformers during catalysis, enabling half of sites of COX activity.


Subject(s)
Cyclooxygenase 1/metabolism , Cyclooxygenase Inhibitors/pharmacology , Fatty Acids/pharmacology , Allosteric Regulation/drug effects , Cyclooxygenase 1/isolation & purification , Humans , Recombinant Proteins/isolation & purification , Recombinant Proteins/metabolism , Structure-Activity Relationship
3.
Protein Expr Purif ; 80(1): 41-6, 2011 Nov.
Article in English | MEDLINE | ID: mdl-21645621

ABSTRACT

We report the expression of a high level of human cyclooxygenase-1 (hCOX-1) in mammalian cells using a novel gene amplification method known as the IR/MAR gene amplification system. IR/MAR-plasmids contain a mammalian replication initiation region (IR) and a nuclear matrix attachment region (MAR) and amplify autonomously without a specific induction process. In this study, the IR/MAR-plasmid pΔBN.AR1 was cotransfected with pCAG-COX1, which expresses hCOX-1, into human HEK293T cells, and G418 and blasticidin S double-resistant cells were obtained in about 1month. Real-time PCR and Western blotting revealed that the expressions of hCOX-1 mRNA and protein in both polyclonal and monoclonal cells were remarkably higher than those in only pCAG-COX1-transfected control cells. Southern blotting demonstrated the amplification of the hCOX-1 gene, and the copy number of clone #43 obtained by the cotransfection of pΔBN.AR1 and pCAG-COX1 was more than 20 copies per cell, though that of clone #14 obtained without using the IR/MAR plasmid pΔBN.AR1 was only two copies. These results indicate that a high level of hCOX-1 expression was achieved as a result of hCOX-1 gene amplification. Furthermore, the crude extract from clone #43 showed a strong COX-1 activity, and the activity was inhibited by the representative COX-1 inhibitor indomethacin, with an IC(50) value of 36nM. These results demonstrate that the IR/MAR gene amplification system is a simple but useful method for generating highly productive mammalian cells.


Subject(s)
Cyclooxygenase 1/genetics , Gene Amplification , Plasmids/genetics , Recombinant Proteins/genetics , Cell Line , Cyclooxygenase 1/isolation & purification , Cyclooxygenase 1/metabolism , Cyclooxygenase Inhibitors/pharmacology , Gene Expression , Humans , Indomethacin/pharmacology , RNA, Messenger/genetics , Recombinant Proteins/isolation & purification , Recombinant Proteins/metabolism , Transfection
4.
Methods Mol Biol ; 644: 21-9, 2010.
Article in English | MEDLINE | ID: mdl-20645162

ABSTRACT

Human recombinant COX-1 and COX-2 was prepared in a purified form. The genes were cloned and expressed in insect cells, extracted by detergents, and purified by ion-exchange followed by size exclusion chromatography. Insect cells from 10 L fermentation yielded 2.3 mg of COX-1 with an overall yield of 75%, and 29 mg of COX-2 with an overall yield of 45%. Enzyme prepared in this manner was fully active and proved to be useful in biophysical studies including direct binding studies. The COX-2 provided material that was subsequently used in X-ray crystallography studies.


Subject(s)
Chromatography, Gel/methods , Chromatography, Ion Exchange/methods , Cyclooxygenase 1/isolation & purification , Cyclooxygenase 2/isolation & purification , Recombinant Proteins/isolation & purification , Animals , Cloning, Molecular , Cyclooxygenase 1/genetics , Cyclooxygenase 1/metabolism , Cyclooxygenase 2/genetics , Cyclooxygenase 2/metabolism , Electrophoresis, Polyacrylamide Gel , Humans , Insecta/cytology , Recombinant Proteins/genetics , Recombinant Proteins/metabolism
5.
Methods Mol Biol ; 644: 31-43, 2010.
Article in English | MEDLINE | ID: mdl-20645163

ABSTRACT

Cyclooxygenase (COX) enzymes play important roles in normal physiology and during inflammation of various cells and tissues. In order to help understand the functions of these enzymes, their genes can be cloned to facilitate the production of the proteins in recombinant form. We outline a method to clone the genes from a human macrophage cell line for expression in an insect cell line infected with recombinant baculovirus encoding these enzymes.


Subject(s)
Baculoviridae/genetics , Cloning, Molecular/methods , Cyclooxygenase 1/genetics , Cyclooxygenase 2/genetics , Insecta/cytology , Recombinant Proteins/genetics , Animals , Cell Line , Cyclooxygenase 1/isolation & purification , Cyclooxygenase 2/isolation & purification , Genetic Vectors , Humans , Plasmids/genetics , Polymerase Chain Reaction/methods , RNA, Messenger/genetics , RNA, Messenger/isolation & purification , Recombinant Proteins/isolation & purification
6.
Methods Mol Biol ; 606: 83-94, 2010.
Article in English | MEDLINE | ID: mdl-20013391

ABSTRACT

In spite of considerable progress in the methodology for reconstitution of membrane proteins into the liposomes, a successful reconstitution still appears to be more an art than a science. Reconstitution of membrane proteins into bilayers is required for establishing several aspects of the functions of membrane proteins and lipids and for elaborating models of naturally occurring membranes.Cyclooxygenase (COX)-1 and -2 (also prostaglandin endoperoxide H(2) synthase, PGHS-1 and -2) belong to the class of monotopic membrane proteins. Membrane-binding domains of both COX-1 and -2 contain four short, consecutive, amphipathic alpha-helices (A, B, C, and D). Crystal structures of the COXs indicate that basic, hydrophobic, and aromatic residues in the membrane-binding domain are oriented away from the protein core and form a surface on the enzyme, which has been proposed to interact with the lipid bilayer (1).In this chapter, we describe a fast and efficient method for direct incorporation of COX-1 and -2 isozymes - as models for monotopic integral membrane proteins - into preformed liposomes containing fatty acids without loss of activity.


Subject(s)
Cyclooxygenase 1/metabolism , Liposomes/metabolism , Membrane Proteins/metabolism , Animals , Baculoviridae/genetics , Cell Line , Cyclooxygenase 1/genetics , Cyclooxygenase 1/isolation & purification , Cyclooxygenase 2/genetics , Cyclooxygenase 2/isolation & purification , Cyclooxygenase 2/metabolism , Fatty Acids/chemistry , Fatty Acids/metabolism , Gene Expression , Liposomes/chemistry , Liposomes/ultrastructure , Membrane Proteins/genetics , Membrane Proteins/isolation & purification , Recombinant Proteins/genetics , Recombinant Proteins/isolation & purification , Recombinant Proteins/metabolism , Spodoptera/genetics
7.
Eur J Pharmacol ; 608(1-3): 84-90, 2009 Apr 17.
Article in English | MEDLINE | ID: mdl-19239910

ABSTRACT

MK-886, an inhibitor of the 5-lipoxygenase-activating protein (FLAP), potently suppresses leukotriene biosynthesis in intact cells and is frequently used to define a role of the 5-lipoxygenase (EC 1.13.11.34) pathway in cellular or animal models of inflammation, allergy, cancer, and cardiovascular disease. Here we show that MK-886 also interferes with the activities of cyclooxygenases (COX, EC 1.14.99.1). MK-886 inhibited isolated COX-1 (IC(50)=8 microM) and blocked the formation of the COX-1-derived products 12(S)-hydroxy-5-cis-8,10-trans-heptadecatrienoic acid (12-HHT) and thromboxane B(2) in washed human platelets in response to collagen as well as from exogenous arachidonic acid (IC(50)=13-15 microM). Isolated COX-2 was less affected (IC(50)=58 microM), and in A549 cells, MK-886 (33 microM) failed to suppress COX-2-dependent 6-keto-prostaglandin (PG)F(1alpha) formation. The distinct susceptibility of MK-886 towards COX-1 and -2 is apparent in automated molecular docking studies that indicate a preferred binding of MK-886 to COX-1 into the active site. MK-886 (10 microM) inhibited COX-1-mediated platelet aggregation induced by collagen or arachidonic acid whereas thrombin- or U-46619-induced (COX-independent) aggregation was not affected. Since leukotrienes and prostaglandins share (patho)physiological properties in the development and regulation of carcinogenesis, inflammation, and vascular functions, caution should be used when interpreting data where MK-886 is used as tool to determine the involvement of FLAP and/or the 5-lipoxygenase pathway in respective experimental models.


Subject(s)
Cyclooxygenase 1/metabolism , Indoles/pharmacology , Lipoxygenase Inhibitors/pharmacology , Platelet Aggregation Inhibitors/pharmacology , Animals , Cell Line, Tumor , Cyclooxygenase 1/isolation & purification , Cyclooxygenase 2/genetics , Cyclooxygenase 2/isolation & purification , Cyclooxygenase 2/metabolism , Dose-Response Relationship, Drug , Humans , Hydrogen Bonding , Indoles/chemistry , Inhibitory Concentration 50 , Lipoxygenase Inhibitors/chemistry , Lung Neoplasms/pathology , Models, Chemical , Molecular Structure , Recombinant Proteins/isolation & purification , Recombinant Proteins/metabolism , Sheep
8.
Biotechnol Lett ; 29(12): 1803-9, 2007 Dec.
Article in English | MEDLINE | ID: mdl-17665137

ABSTRACT

We examined the expression of human cyclooxygenase-1 (COX-1) in Drososphila melanogaster S2 (S2) cells transformed with cDNAs encoding beta1,4-galactosyltransferase (GalT) and Galbeta1,4-GlcNAc alpha2,6-sialyltransferase (ST). Southern blot analysis indicated that multiple copies of the glycosyltransferases genes were integrated into the S2 cell genome. A lectin blot analysis also indicated that recombinant COX-1 from S2COX-1/GalT-ST cells contained the glycan residues of beta1,4-linked galactose and alpha2,6-linked sialic acid. The specific peroxidase activity of recombinant sialylated COX-1 from S2COX-1/GalT-ST cells was 41,250 U mg(-1), indicating an increase of approximately 22% compared with a non-sialylated control (33,850 U mg(-1)) from S2COX-1 cells.


Subject(s)
Cyclooxygenase 1/metabolism , Drosophila melanogaster/cytology , Drosophila melanogaster/enzymology , Galactosyltransferases/metabolism , Recombinant Proteins/metabolism , Sialyltransferases/metabolism , Transformation, Genetic , Animals , Blotting, Southern , Cell Line , Cyclooxygenase 1/isolation & purification , Drosophila melanogaster/genetics , Genome, Insect , Humans , Lectins , Peroxidase , Plasmids , beta-D-Galactoside alpha 2-6-Sialyltransferase
9.
Nat Protoc ; 1(4): 1915-21, 2006.
Article in English | MEDLINE | ID: mdl-17487176

ABSTRACT

The cyclooxygenase (COX) reaction can be monitored by measurement of oxygen consumption, peroxidase co-substrate oxidation or prostaglandin (PG) detection. This protocol describes a procedure measuring cyclooxygenase activity by quantifying PGE2 produced by enzymatic conversion of arachidonic acid, in the presence or absence of potential inhibitors. This high-throughput method has the advantage that it directly measures cyclooxygenase activity and requires little enzyme. The first part of the assay consists of incubating arachidonic acid, cyclooxygenase and the test samples to generate prostaglandins. The second part uses an ELISA method to quantify the amount of PGE2 produced by the enzymatic reaction. The isolation of COX-1 and COX-2 enzymes is also described. This protocol can be completed in approximately 23 h, including 16-h and 4-h incubation phases. This does not include enzyme preparation (3 h for COX-1 and 24 h for COX-2) or preparation of ELISA plates (23 h, including incubation).


Subject(s)
Cyclooxygenase Inhibitors/analysis , Enzyme-Linked Immunosorbent Assay/methods , Animals , Cyclooxygenase 1/isolation & purification , Cyclooxygenase 2/isolation & purification , Dinoprostone/analysis , Humans , Sheep , Spodoptera
10.
Arch Biochem Biophys ; 443(1-2): 60-5, 2005 Nov 15.
Article in English | MEDLINE | ID: mdl-16212933

ABSTRACT

To study the physical and catalytic properties of purified membrane proteins, it is often necessary to reconstitute them into lipid bilayers. Here, we describe a fast efficient method for the direct incorporation of cyclooxygenase-1 and -2 (COX-1 and -2) isozymes into liposomes without loss of activity. Purified COX-1 and -2 spontaneously incorporate into large unilamellar vesicles produced from a mixture of DOPC:DOPS (7:3) that has been doped with oleic acid. When incorporation was measured by comparing cyclooxygenase activity to total phospholipid in the proteoliposomes, molar reconstitution ratios of 1000:1 (phospholipid:COX) were obtained. Electron paramagnetic resonance spectroscopic spin counting analysis of proteoliposomes formed with nitroxide spin-labeled COX-2 gave a nearly identical phospholipid:COX ratio, confirming that incorporation had no effect on enzyme activity, and demonstrating that the efficiency of protein incorporation is sufficient for EPR spectroscopic analysis. The spontaneous incorporation of cyclooxygenase into intact liposomes allows only insertion into the outer leaflet for this monotopic enzyme, an orientation confirmed by immunogold staining of the proteoliposomes. This method of reconstitution into liposomes may be generally applicable to the class of monotopic integral membrane proteins typified by the cyclooxygenase isozymes.


Subject(s)
Chemical Fractionation/methods , Cyclooxygenase 1/chemistry , Cyclooxygenase 1/isolation & purification , Cyclooxygenase 2/chemistry , Cyclooxygenase 2/isolation & purification , Liposomes/chemistry , Spodoptera/enzymology , Animals , Cell Line , Prostaglandin-Endoperoxide Synthases/chemistry , Prostaglandin-Endoperoxide Synthases/isolation & purification
11.
J Pharmacol Exp Ther ; 315(3): 1331-7, 2005 Dec.
Article in English | MEDLINE | ID: mdl-16144976

ABSTRACT

Benzoic acid, 2-(acetyl-oxy)-3-[(nitrooxy)methyl]phenyl ester (NCX 4016), a new drug made by an aspirin molecule linked, through a spacer, to a nitric oxide (NO)-donating moiety, is now under clinical testing for the treatment of atherothrombotic conditions. Aspirin exerts its antithrombotic activity by irreversibly inactivating platelet cyclooxygenase (COX)-1. NCX 4016 in vivo undergoes metabolism into deacetylated and/or denitrated metabolites, and it is not known whether NCX 4016 needs to liberate aspirin to inhibit COX-1, or whether it can block it as a whole molecule. The aim of our study was to evaluate the effects of NCX 4016 and its analog or metabolites on platelet COX-1 and whole blood COX-2 and on purified ovine COX (oCOX)-1 and oCOX-2. In particular, we have compared the mechanism by which NCX 4016 inhibits purified oCOX enzymes with that of aspirin using a spectrophotometric assay. All the NCX 4016 derivatives containing acetylsalicylic acid inhibited the activity of oCOX-1 and oCOX-2, whereas the deacetylated metabolites and the nitric oxide-donating moiety were inactive. Dialysis experiments showed that oCOX-1 inhibition by NCX 4016, similar to aspirin, is irreversible. Reversible COX inhibitors (indomethacin) or salicylic acid incubated with the enzyme before NCX 4016 prevent the irreversible inhibition of oCOX-1 by NCX 4016 as well as by aspirin. In conclusion, our data show that NCX 4016 acts as a direct and irreversible inhibitor of COX-1 and that the presence of a spacer and NO-donating moiety in the molecule slows the kinetics of COX-1 inhibition by NCX 4016, compared with aspirin.


Subject(s)
Aspirin/analogs & derivatives , Cyclooxygenase Inhibitors/pharmacology , Platelet Aggregation Inhibitors/pharmacology , Animals , Aspirin/chemistry , Aspirin/pharmacology , Blood Platelets/enzymology , Blood Platelets/metabolism , Cyclooxygenase 1/isolation & purification , Cyclooxygenase 2/blood , Cyclooxygenase Inhibitors/blood , Cyclooxygenase Inhibitors/chemistry , Dialysis , Dinoprostone/analysis , Dinoprostone/metabolism , Dose-Response Relationship, Drug , Hemostatics/pharmacology , Humans , Kinetics , Molecular Structure , Monocytes/enzymology , Monocytes/metabolism , Sheep , Spectrophotometry , Thrombin/pharmacology , Thromboxane B2/analysis , Thromboxane B2/metabolism , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...